`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`COSMO TECHNOLOGIES LIMITED,
`Patent Owner.
`
`
`Case IPR2017-01035
`
`Patent 9,320,716
`
`
`
`PETITIONER’S MOTION TO EXPUNGE
`
`
`
`
`
`
`
`
`I.
`
`Introduction
`
`Pursuant to the Board’s authorization via email on July 7, 2017, Petitioner
`
`hereby moves to expunge the redacted Patent Owner’s Preliminary Response
`
`(“Original Redacted Preliminary Response”) (Paper 8) from the public record. As
`
`explained in the concurrently filed Petitioner’s Motion to Seal, Public disclosure of
`
`the information that Petitioner seeks to have sealed would be commercially
`
`harmful to Petitioner. The Original Redacted Preliminary Response does not
`
`redact each of the portions of sentences Petitioner seeks to seal. Thus, Petitioner
`
`moves to expunge the Original Redacted Preliminary Response from the public
`
`record.
`
`II. Legal Standard
`
`“Where confidentiality is alleged as to some but not all of the information
`
`submitted to the Board, the submitting party shall file confidential and non-
`
`confidential versions of its submission, together with a Motion to Seal the
`
`confidential version setting forth the reasons why the information redacted from
`
`the non-confidential version is confidential and should not be made publicly
`
`available.” Office Trial Practice Guide, 77 Fed. Reg. at 48,756, 48,770 (Aug. 14,
`
`2012); see also id. at 48,771. The movant must “(1) explain why each portion of
`
`the information . . . it seeks to redact constitutes ‘confidential information’ as
`
`defined in 37 C.F.R. §42.2; and (2) explain why good cause exists for each
`
`
`
`
`1
`
`
`
`
`
`
`redaction.” Altaire Pharm., Inc. v. Paragon Bioteck, Inc., PGR2015-0001, Paper
`
`27 at 3 (PTAB Mar. 29, 2016).
`
`III. Confidential Documents that Should be Expunged from the Record
`
`As explained in the concurrently filed Petitioner’s Motion to Seal the Patent
`
`Owner’s Preliminary Response (Paper 7), the Patent Owner’s Preliminary
`
`Response reveals information regarding Petitioner’s ANDA product, specifically
`
`the following passages:
`
`
`
`
`
`
`
`The portion of the sentence on page 6, footnote 2, the parenthetical at
`line 6 that is between the phrases “prove infringement” and “is
`nevertheless”;
`
`The portion of the sentence on page 36 lines 6-8 that is between the
`phrases “in district court litigation—” and “—should be rejected”; and
`
`The portion of the sentence on page 51 lines 9-11 that is between the
`phrases “in district court litigation—” and “—should be rejected.”
`
`The identified portions directly provide information regarding Petitioner’s
`
`ANDA product—specifically how the active ingredient in Petitioner’s ANDA
`
`product is distributed. The Original Redacted Preliminary Response does not
`
`redact the portion of the sentence on page 6, footnote 2 line 6 that Petitioner seeks
`
`to seal. Information regarding Petitioner’s ANDA product is trade secret and/or
`
`confidential commercial information, thus qualifies as confidential information
`
`under 37 CFR § 42.2.
`
`The redactions in the Original Redacted Preliminary Response are only
`
`applied to, as indicated by the Patent Owner’s Motion to Seal, the portions that are
`
`
`
`
`2
`
`
`
`
`
`
`purportedly quoting the excerpts from the trial transcript in Cosmo Techs. Ltd. v.
`
`Actavis Labs. FL, No. 15-164-LPS (D. Del. May 23, 2017) (the “Transcript”)
`
`(Exhibit 2025). See Patent Owner’s Motion to Seal, Paper 9 at 3. The Original
`
`Redacted Preliminary Response, however, does not contain redactions with respect
`
`to other portions that reveal information regarding the Petitioner’s ANDA product,
`
`specifically the portion of the sentence on page 6, footnote 2 line 6 that Petitioner
`
`seeks to seal. Petitioner agrees to file a further revised Redacted Preliminary
`
`Response that redacts the confidential information that is subject to the
`
`concurrently filed Petitioner’s Motion to Seal, if granted, and redacts the
`
`confidential information that is subject to Patent Owner’s Motion to Seal (Paper 9),
`
`if granted, or upon the request from the Board.
`
`Good cause exists because public disclosure of the information that
`
`Petitioner seeks to have sealed and redacted would disclose confidential
`
`information in a highly competitive market. This information has not been
`
`published and is not publicly available. Disclosure of this confidential information
`
`would allow competitors to ascertain how Petitioner’s ANDA product is made and
`
`potentially the testing performed by Petitioner during its manufacture, which is
`
`confidential and competitive information to Petitioner.
`
`Petitioner understands that the rules promulgated by the USPTO “aim to
`
`strike a balance between the public’s interest in maintaining a complete and
`
`
`
`
`3
`
`
`
`
`
`
`understandable file history and the parties’ interest in protecting truly sensitive
`
`information.” Office Trial Practice Guide, 77 Fed. Reg. 48,756, 48,760 (Aug. 14,
`
`2012). Petitioner contends that its redactions—constituting only portions of a few
`
`sentences—are minimal and are far less than those proposed by Patent Owner in its
`
`Motion to Seal (Paper 9). Even with Petitioner’s proposed redactions the public
`
`will be left with a complete and understandable file history, only being unaware of
`
`the distribution of ingredient component in Petitioner’s ANDA product.1 Sandoz,
`
`Inc. v. EKR Therapeutics, LLC, IPR2015-00005, Paper 21 at 4 (PTAB Apr. 24,
`
`2014) (“The redactions to the Petitioner’s Reply appear to be limited to isolated
`
`passages that consist entirely of confidential commercial information. The
`
`redactions made
`
`to
`
`the Petitioner’s Reply would not inhibit a reader’s
`
`understanding of the substance of the Petitioner’s position.”). Petitioner contends
`
`that such information would not impede the public’s understanding of Patent
`
`Owner’s Preliminary Response and strikes the appropriate balance between the
`
`public’s interest and Petitioner’s interest in protecting its confidential information.
`
`
`1 Indeed, coupled with the statements in this Paper, the public will
`
`understand what the redacted information generally relates to, left only without
`
`information about the distribution of ingredient component in Petitioner’s ANDA
`
`product.
`
`
`
`
`4
`
`
`
`
`
`
`Patent Owner will argue that the passage of time between the filing of the
`
`Patent Owner’s Preliminary Response on Thursday, June 22, 2017 and Petitioner’s
`
`email to the Board to seek authorization to move to expunge on Wednesday, July
`
`5, 2017 precludes the submission of a redacted copy. That characterization ignores
`
`the fact that Patent Owner filed the Preliminary Response which contained
`
`Petitioner’s confidential information without first conferring with Petitioner. See
`
`Patent Owner’s Motion to Seal (Paper 9), making no representation that Patent
`
`Owner met and conferred with Petitioner.
`
`Because the document at issue was Patent Owner’s Preliminary Response,
`
`not Petitioner’s filing, Petitioner believed that Petitioner could not unilaterally
`
`move to expunge without first meeting and conferring with Petitioner. Further,
`
`Board authorization was required before filing any motion. 37 C.F.R. § 42.20(b).
`
`Accordingly, as soon as Petitioner learned that the Original Unredacted
`
`Preliminary Response revealed Petitioner’s confidential information, Petitioner
`
`contacted Patent Owner on Tuesday, June 27, 2017 to meet and confer in order to
`
`resolve the issue. Patent Owner was not available to meet and confer until
`
`Thursday, June 29, 2017 at 5PM Eastern. The parties met and conferred by
`
`telephone on June 29, 2017 and after the call Petitioner sent Patent Owner
`
`proposed redactions that Petitioner planned to seek. Patent Owner requested a
`
`second meet on confer on Friday, June 30, 2017, which Petitioner’s counsel
`
`
`
`
`5
`
`
`
`
`
`
`obliged later that same day even though Petitioner’s counsel was traveling. On
`
`Wednesday, July 5, 2017, after the intervening Independence Day holiday,
`
`Petitioner contacted the Board seeking authorization to expunge the Original
`
`Unredacted Preliminary Response. The Board gave authorization on Friday, July
`
`7, 2017. As this timeline shows, Patent Owner was diligent and any alleged delay
`
`was caused by Patent Owner’s failure to timely resolve the matter through meet
`
`and confer. Patent Owner’s delay tactics should not justify publicly revealing
`
`Petitioner’s confidential information.
`
`Accordingly, Petitioner hereby moves to expunge the Original Redacted
`
`Preliminary Response and replace it with the Replacement Redacted Preliminary
`
`Response.
`
`IV. Conclusion
`
`
`
`For the foregoing reasons, Petitioner respectfully requests that the Board
`
`expunge the Original Redacted Preliminary Response and enter a replacement
`
`redacted Preliminary Response that will be prepared and submitted according to
`
`the Board’s granting of Petitioner’s Motion to Seal and/or Patent Owner’s Motion
`
`to Seal. The replacement redacted Preliminary Response would thus remain
`
`publicly available. Expungement will protect Petitioner’s confidential information
`
`without comprising the public’s ability to understand the record.
`
`
`
`
`
`
`6
`
`
`
`
`
`
`Date: July 13, 2017
`
`
`
`
`
`Respectfully submitted,
`
`Alston & Bird LLP
`
`By: /Jitendra Malik/
`
`Jitendra Malik, Ph.D.
`Reg. No. 55823
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`jitty.malik@alston.com
`
`Lead Counsel for Petitioner
`
`
`
`
`7
`
`
`
`
`
`CERTIFICATION OF SERVICE
`
`Pursuant to 37 C.F.R. §§ 42.6(e), 42.8(b)(4) and 42.105, the undersigned
`
`certifies that on the 13th day of July, 2017, a complete copy of the foregoing
`
`Petitioner’s Motion to Expunge was served on counsel of record for the Patent
`
`Owner:
`
`Gary N. Frischling (Reg. No. 35,515)
`gfrischling@irell.com
`
`Yite John Lu (Reg. No. 63,158)
`yjlu@irell.com
`
`CosmoIPR@irell.com
`
`
`
`
`
`Respectfully submitted,
`
`Alston & Bird LLP
`
`By: /Jitendra Malik/
`
`Jitendra Malik, Ph.D.
`Reg. No. 55823
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`jitty.malik@alston.com
`
`Lead Counsel for Petitioner
`
`1
`
`